Rhineland-Palatinate lender ISB takes stake in stroke-treatment startup CatMedica

• Investitions- und Strukturbank Rheinland-Pfalz (ISB) took an equity stake in Mainz-based medtech startup CatMedica via WFT.
• Funding came from the Innovationsfonds Rheinland-Pfalz III, a venture financing vehicle backed by the state government, with EU co-financing.
• CatMedica develops ThrombeXwire, a device designed to remove blood clots from vessels on the first attempt, targeting improved stroke treatment outcomes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Investitionsund Strukturbank Rheinland-Pfalz ISB published the original content used to generate this news brief on September 23, 2026, and is solely responsible for the information contained therein.